Published: 4/13/2021 1:24:51 PM
Days after more than 10,000 doses of the Johnson and Johnson vaccine were doled out at the New Hampshire Motor Speedway, the state will temporarily stop administering the shots to comply with recommendations from federal health agencies.
The Centers for Disease Control and the Federal Drug Administration called for an immediate pause in the use of the Johnson & Johnson vaccine after six women developed a blood clot disorder shortly after receiving their dose. The adverse vaccine reaction still appears to be extremely rare, though severe one woman from Nebraska died from the clot and another woman is in critical condition. More than 6.8 million Americans have received this vaccine without developing this blood clot condition.
CONCORD, N.H. (AP) New Hampshire is following federal recommendations to pause the use of the single-dose Johnson & Johnson COVID-19 vaccine. The Centers for Disease Control and Prevention.
Days after more than 10,000 doses of the Johnson and Johnson vaccine were doled out at the New Hampshire Motor Speedway, the state will temporarily stop administering the shots to comply with recommendations from federal health agencies.The Centers.
N.H. pauses use of Johnson & Johnson vaccine
Update: Tuesday, April 13, 10:17 a.m.
Gov. Chris Sununu announced New Hampshire would pause use of the Johnson & Johnson COVID-19 vaccine after the CDC and FDA issued a recommendation earlier today, following reports of six people in the U.S. developing a rare disorder involving blood clots within two weeks after vaccination.
The announcement comes after a third mass vaccination clinic this past weekend at New Hampshire Motor Speedway in Loudon, which used the J&J vaccine. Sununu was among those getting the vaccine which is a one-dose vaccine, as opposed to Moderna and Pfizer, which require two doses.